Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Thc Therapeutics Inc (THCT)

Thc Therapeutics Inc (THCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 +100.00%
on 02/10/26
0.0190 -98.95%
on 02/10/26
-0.0188 (-98.95%)
since 02/09/26
3-Month
0.0001 +100.00%
on 02/10/26
0.0195 -98.97%
on 01/30/26
unch (unch)
since 12/02/25
52-Week
0.0001 +100.00%
on 02/10/26
0.0300 -99.33%
on 08/15/25
-0.0001 (-33.33%)
since 02/28/25

Most Recent Stories

More News
THC Therapeutics, Inc. Announces Filing of 10-K and Provides Corporate Update

JACKSBORO, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (OTC: THCT), a dynamic and growing cannabis company, issued a shareholder update today. To our valued friends and shareholders,...

THCT : 0.0002 (-98.94%)
THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery

THCT : 0.0002 (-98.94%)
THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies

THCT : 0.0002 (-98.94%)
Kevin Bell CO-Founder & CEO of Kali Partners/VP of Tyson 2.0 joins THC Therapeutics

THCT plans for growth with focus on potential acquisitions in the Cannabis and Psychedelics industries - THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded technology company, whose mission...

THCT : 0.0002 (-98.94%)
THC Therapeutics Has Entered Into Agreement for up to $50 Million in Funding With a Private Equity Firm for M&A in the Cannabis Industry

Groundbreaking Leap Forward in THCT's New Business Plan. LAS VEGAS, NV / ACCESSWIRE / September 10, 2021 / THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded technology company, whose mission...

THCT : 0.0002 (-98.94%)
THC Therapeutics Appoints New CFO

Jonathan Cross, a private equity fund manager with over 33 years of experience, joins THC Therapeutics LAS VEGAS, NV / ACCESSWIRE / August 31, 2021 / THC Therapeutics, Inc. (THCT), a forward-thinking,...

THCT : 0.0002 (-98.94%)
THC Therapeutics Exploring Entry Into Silver Market as an Online Precious Metals Dealer

THCT Investigating Unique Strategy in Precious Metals Industry With a Special Interest in Silver Assets LAS VEGAS, NV / ACCESSWIRE / May 26, 2021 / THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded...

THCT : 0.0002 (-98.94%)
^MTLBTC : 0.0000041 (unch)
THC Therapeutics Hires Dr. Jesse Dean III, Former Chiropractor of the Memphis Grizzlies & Sports Agent

THCT has signed a contract with Dr. Dean to introduce and negotiate an agreement between THC Therapeutics and one or more well-known celebrities in the cannabis industry that will join the board of directors...

THCT : 0.0002 (-98.94%)
THC Therapeutics Has Completed the dHydronator(R) Consumer Model Design

THCT has leveraged the extensive market research commissioned through Keyhole Research to redesign the dHydronator® for the consumer market. This new design is in the rapid prototyping phasein preparation...

THCT : 0.0002 (-98.94%)

Key Turning Points

3rd Resistance Point 0.0189
2nd Resistance Point 0.0189
1st Resistance Point 0.0189
Last Price 0.0002
1st Support Level 0.0189
2nd Support Level 0.0189
3rd Support Level 0.0189

See More

52-Week High 0.0300
Fibonacci 61.8% 0.0186
Fibonacci 50% 0.0150
Fibonacci 38.2% 0.0115
Last Price 0.0002
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar